Brand Post April 14, 2025 Offshoring solutions provider Yempo to run 2025 Australia roadshow SYDNEY, April 14, 2025 (GLOBE NEWSWIRE) — From 12 May to 10 June, industry-leading specialist offshoring solutions company Yempo will…
Brand Post April 14, 2025 Transactions Made Under the Share Buy-back Programme for Stolt-Nielsen Limited Reference is made to the stock exchange announcement from Stolt-Nielsen Limited (Oslo Børs: SNI) on April 3, 2025 regarding the…
Brand Post April 14, 2025 Elis: Disclosure of trading in own shares occured from April 7 to April 9, 2025 Disclosure of trading in own shares occurred from April 7 to April 9, 2025 Saint-Cloud, April 14, 2025 In accordance…
Brand Post April 14, 2025 Q1-2025 Production Results, Operational Highlights and Board Change Q1-2025 Production Results, Operational Highlights and Board Change Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian…
Brand Post April 14, 2025 Endeavour to Announce Its Q1 2025 Results on 1 May 2025 ENDEAVOUR TO ANNOUNCE ITS Q1 2025 RESULTS ON 1 MAY 2025 London, 14 April 2025 – Endeavour Mining plc…
Brand Post April 14, 2025 InfiMotion Technology Revolutionizes EV Powertrains with Groundbreaking 12-in-1 Electric Drive Unit (EDU) WUXI, China, April 14, 2025 (GLOBE NEWSWIRE) — InfiMotion Technology, a leading innovator in electric vehicle (EV) powertrain solutions, today…
Brand Post April 14, 2025 McPhy Energy: Opening of conciliation proceedings Foussemagne (France), April 14, 2025 – 7:30 am CEST – McPhy Energy, manufacturer of alkaline electrolyzers (“McPhy“), announces the opening,…
Brand Post April 14, 2025 CORRECTION – New Guideline Aims to Transform Obesity Care for Children and Adolescents First Canadian update in nearly 20 years prioritizes improvements in health and quality of life over weight loss outcomes EDMONTON,…
Brand Post April 14, 2025 European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk…
Brand Post April 14, 2025 Press release: CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases New Technology Add-on Payment (NTAP)…
Brand Post April 14, 2025 Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar…
Brand Post April 14, 2025 Fortescue and CMB.TECH sign agreement for ammonia-powered ore carrier Antwerp, April 14, 2025 (GLOBE NEWSWIRE) — CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) has signed…